Difference between revisions of "Team:Birkbeck/Modeling"

Line 19: Line 19:
 
   <th><img src="https://static.igem.org/mediawiki/2015/d/d4/Birkbeck_phage.png" height=200 width=100>  
 
   <th><img src="https://static.igem.org/mediawiki/2015/d/d4/Birkbeck_phage.png" height=200 width=100>  
 
       </th>
 
       </th>
−
   <td>Short tail fibre (stf) and reporter genes are cloned into a GT11 bacteriophage lambda vector, while regulatory circuits are created to control both the transfer between lytic/lysogenic cycle and the production of the tail fibre assembly (tfa) protein, in order to prevent toxicity to the host cell. The circularised GT11 vector and plasmids containing the regulatory circuits are transformed into E.coli host cells.</td>
+
   <td>Short tail fibre (stf) and reporter genes are cloned into a GT11 bacteriophage lambda vector.</td>
 
</tr>
 
</tr>
 
</table>
 
</table>
Line 32: Line 32:
 
     width:200px;
 
     width:200px;
 
}
 
}
 +
</style>
  
 +
<table class="lamp">
 +
<tr>
 +
  <th><img src="https://static.igem.org/mediawiki/2015/0/09/Birkbeck_circuit_development.png" height=100 width=200>
 +
      </th>
 +
  <td>Regulatory circuits are created to control the production of the tail fibre assembly (tfa) protein and the switch between lytic/lysogenic cycles of the bacteriophage. While AraC is produced, production of T7 RNA polymerase (RNAP) is inhibited, resulting in production of the cI repressor dominating and the bacteriophage remaining in lysogenic phase. On the addition of arabinose, AraC preferentially binds to to this molecule, dissociating from the promoter controlling T7 RNAP. As a result, T7 RNAP is produced, which initiates production of the Cro repressor, overriding cI production and placing the bacteriophage into the lytic phase.</td>
 +
</tr>
 +
</table>
 +
 +
<style>
 +
table.lamp {
 +
    width:100%;
 +
    text-align:justify;
 +
 +
}
 +
table.lamp th {
 +
    width:200px;
 +
}
 
</style>  
 
</style>  
−
</ul>
 
  
 +
<table class="lamp">
 +
<tr>
 +
  <th><img src="https://static.igem.org/mediawiki/2015/8/81/Birkbeck_phage_infection.png" height=200 width=200>
 +
      </th>
 +
  <td>The circularised GT11 vector and plasmids containing the regulatory circuits are transformed into E.coli host cells, and the host machinery is used to create a recombinant bacteriophage containing our desired mutations and additions.</td>
 +
</tr>
 +
</table>
 +
 +
<style>
 +
table.lamp {
 +
    width:100%;
 +
    text-align:justify;
 +
 +
}
 +
table.lamp th {
 +
    width:200px;
 +
}
 +
</style>
 +
 +
<table class="lamp">
 +
<tr>
 +
  <th><img src="https://static.igem.org/mediawiki/2015/a/af/Birkbeck_phages2.png" height=200 width=200>
 +
      </th>
 +
  <td>On addition of arabinose, the recombinant phage progeny goes into lytic phase and emerges from the lysed host cells.</td>
 +
</tr>
 +
</table>
 +
 +
<style>
 +
table.lamp {
 +
    width:100%;
 +
    text-align:justify;
 +
 +
}
 +
table.lamp th {
 +
    width:200px;
 +
}
 +
</style>
 +
 +
 +
<table class="lamp">
 +
<tr>
 +
  <th><img src="https://static.igem.org/mediawiki/2015/a/af/Birkbeck_phages2.png" height=200 width=200>
 +
      </th>
 +
  <td>Addition of arabinose</td>
 +
</tr>
 +
</table>
 +
 +
<style>
 +
table.lamp {
 +
    width:100%;
 +
    text-align:justify;
 +
 +
}
 +
table.lamp th {
 +
    width:200px;
 +
}
 +
</style>
  
  
 
</div>
 
</div>
 
</html>
 
</html>

Revision as of 11:30, 18 September 2015

Modelling

Modelling the directed evolution of bacteriophage lambda

To accomplish the goal of altering the host specificity of bacteriophage lambda, we took a step-by-step directed evolution approach, working according to the 'design - build - model - test - repeat' principle. This started with the design of several mutations both to alter the phage phenotype and to make segments of its genotype BioBrick-compatible. We then proceeded to 'build' individual genes through synthesis and cloning. The next steps are to recombine these genes into a recombinant bacteriophage genome, before carrying out testing and selection, and repeating this process.


The process is as follows:

Short tail fibre (stf) and reporter genes are cloned into a GT11 bacteriophage lambda vector.
Regulatory circuits are created to control the production of the tail fibre assembly (tfa) protein and the switch between lytic/lysogenic cycles of the bacteriophage. While AraC is produced, production of T7 RNA polymerase (RNAP) is inhibited, resulting in production of the cI repressor dominating and the bacteriophage remaining in lysogenic phase. On the addition of arabinose, AraC preferentially binds to to this molecule, dissociating from the promoter controlling T7 RNAP. As a result, T7 RNAP is produced, which initiates production of the Cro repressor, overriding cI production and placing the bacteriophage into the lytic phase.
The circularised GT11 vector and plasmids containing the regulatory circuits are transformed into E.coli host cells, and the host machinery is used to create a recombinant bacteriophage containing our desired mutations and additions.
On addition of arabinose, the recombinant phage progeny goes into lytic phase and emerges from the lysed host cells.
Addition of arabinose